JGAVX | RMEBX | JGAVX / RMEBX | |
Total Expense Ratio | 0.94 | 1.07 | 88% |
Annual Report Gross Expense Ratio | 1.01 | 1.07 | 94% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 6.595 | 9.641 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.47B | 109B | 6% |
Annual Yield % from dividends | 1.07 | 1.12 | 96% |
Returns for 1 year | 9.17 | 9.49 | 97% |
Returns for 3 years | 40.50 | 30.38 | 133% |
Returns for 5 years | 83.56 | 57.31 | 146% |
Returns for 10 years | N/A | 74.78 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RNPCX | 67.64 | 0.13 | +0.19% |
American Funds New Perspective R3 | |||
FLDGX | 14.39 | N/A | N/A |
Meeder Dynamic Allocation Retail | |||
ETAHX | 33.53 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
BEXIX | 17.53 | N/A | N/A |
Baron Emerging Markets Institutional | |||
JHSMX | 12.19 | N/A | N/A |
JHancock International Small Company R6 |